|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2010-8-31
|
|
pubmed:abstractText |
Porfimer is an intravenous (i.v.) injectable photosensitizing agent used in the photodynamic treatment of tumours and of high-grade dysplasia in Barrett's oesophagus.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1365-2036
|
|
pubmed:author |
pubmed-author:AckroydRR,
pubmed-author:AyaruLL,
pubmed-author:FullartonGG,
pubmed-author:GanMM,
pubmed-author:GrzebieniakZZ,
pubmed-author:MessmannHH,
pubmed-author:MittonDD,
pubmed-author:OrtnerM-AMA,
pubmed-author:PereiraS PSP,
pubmed-author:SpénardJJ,
pubmed-author:TrinhM MMM,
pubmed-author:ZammitMM
|
|
pubmed:copyrightInfo |
2010 Axcan Pharma Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
821-7
|
|
pubmed:meshHeading |
pubmed-meshheading:20629974-Adenocarcinoma,
pubmed-meshheading:20629974-Aged,
pubmed-meshheading:20629974-Barrett Esophagus,
pubmed-meshheading:20629974-Dihematoporphyrin Ether,
pubmed-meshheading:20629974-Esophageal Neoplasms,
pubmed-meshheading:20629974-Female,
pubmed-meshheading:20629974-Humans,
pubmed-meshheading:20629974-Male,
pubmed-meshheading:20629974-Middle Aged,
pubmed-meshheading:20629974-Photochemotherapy,
pubmed-meshheading:20629974-Photosensitizing Agents,
pubmed-meshheading:20629974-Statistics as Topic,
pubmed-meshheading:20629974-Time Factors,
pubmed-meshheading:20629974-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
The pharmacokinetics and safety of porfimer after repeated administration 30-45 days apart to patients undergoing photodynamic therapy.
|
|
pubmed:affiliation |
UCL Division of Surgery & Interventional Science, London, UK. stephen.pereira@ucl.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
